Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. acta pharmacologica sinica 
3. original article 
4. article
Show authors
•  Original Article
•  Published: 01 March 2007


Pulmonary Pharmacology
Effect of TGF-β/Smad signaling
pathway on lung myofibroblast
differentiation
•  Li Gu1,
•  Yuan-jue Zhu
1,
•  Xiao Yang2,
•  Zi-jian Guo1,
•  Wen-bing Xu1 &
•  …
•  Xin-lun Tian1 
Acta Pharmacologica Sinica volume 28, pages 382–391 (2007)Cite
this article
•  7562 Accesses
•  158 Citations
•  3 Altmetric
•  Metrics details
Abstract
Aim:
Myofibroblasts play important roles in the pathogenesis of lung
fibrosis. Transforming growth factor (TGF)-β1 has been widely
recognized as a key fibrogenic cytokine. The major signaling
pathway of TGF-β1 is through cytoplasmic Smad proteins. Our
study investigated the role of individual TGF-β1/Smad signal
proteins in mediating α-smooth muscle actin (α-SMA) gene
expression, which is a well-known key marker of myofibroblast


differentiation.
Methods:
We transiently cotransfected α-SMA promoter-luciferase fusion
plasmid (p895-Luc) and Smad expression plasmids and measured
Luc activity in TGF-β1-treated human fetal lung fibroblasts. We
induced Smad3 knockout mice lung fibrosis by bleomycin. α-SMA
protein expression was assessed by Western blotting. Collagen
protein was analyzed by measuring hydroxyprolin. Myofibroblast
morphology was assessed by immunohistochemistry.
Results:
We found that the overexpression of Smad3, not Smad2 markedly
increased TGF-β1-induced α-SMA promoter activity and α-SMA
protein expression in vitro, whereas the over-expression of dominant
negative mutant Smad3 and Smad7 repressed TGF-β1 induced α-
SMA gene expression. Compared to wild-type mice, Smad3
knockout mice showed attenuated lung fibrosis after bleomycin
treatment, manifested by lower collagen production and
myofibroblast differentiation.
Conclusion:
Our study suggested TGF-β1/Smad3 is a major pathway which
regulated the myofibroblast differentiation. This result indicates a
potential significance for future attempts of attenuating the
progression of human lung fibrosis by the inhibition of the Smad3
cascade.
Similar content being viewed by others
[image]
AAV9-Tspyl2 gene therapy retards bleomycin-induced
pulmonary fibrosis by modulating downstream TGF-β
signaling in mice


Article Open access 30 June 2023
[image]
Allicin induced AMPK signaling attenuated Smad3
pathway mediated lung fibrosis
Article Open access 30 May 2025
[image]
PD-L1 mediates lung fibroblast to myofibroblast
transition through Smad3 and β-catenin signaling
pathways
Article Open access 23 February 2022
Log in or create a free account to read this
content
Gain free access to this article, as well as selected content from this
journal and more on nature.com
 Access through your institution
or
 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
References
1. Gross TJ, Hunninghake GW . Idiopathic pulmonary fibrosis. N
Engl J Med 2001; 345: 517–25.
Article  CAS  Google Scholar 


2. King, TE Jr, Schwarz, MI, Brown K, Tooze JA, Colby TV,
Waldron, JA Jr, et al. Idiopathic pulmonary fibrosis:
relationship between histopathologic features and mortality.
Am J Respir Crit Care Med 2001; 164: 1025–32.
Article  Google Scholar 
3. Phan SH . The myofibroblasts in pulmonary fibrosis. Chest
2001; 120: S286–S9.
Google Scholar 
4. Kuhn C, McDonald JA . The roles of the myofibroblast in
idiopathic pulmonary fibrosis. Ultrastructural and
immunohistochemical features of sites of active extracellular
matrix synthesis. Am J Pathol 1991; 138: 1257–65.
CAS  PubMed  PubMed Central  Google Scholar 
5. Zhang K, Rekhter MD, Gordon D, Phan SH . Myofibroblasts
and their role in lung collagen gene expression during
pulmonary fibrosis. A combined immunohistochemical and in
situ hybridization study. Am J Pathol 1994; 145: 114–25.
CAS  PubMed  PubMed Central  Google Scholar 
6. Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S,
Horie T . Tranaforming growth factor-β1 induces phenotypic
modulation of human lung fibroblasts to myofibroblasts
through a c-jun-NH2–terminal kinase-dependent pathway. Am
J Respir Crit Care Med 2001; 163: 152–7.
Article  CAS  Google Scholar 
7. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J .
Adenovector-mediated gene transfer of active transforming
growth factor beta1 induceds prolonged severe fibrosis in rat
lung. J Clin Invest 1997; 100: 768–76.
Article  CAS  Google Scholar 
8. Border WA, Noble NA . Transforming growth factor beta in


tissue fibrosis. N Engl J Med 1994; 331: 1286–92.
Article  CAS  Google Scholar 
9. Shi Y, Massague J . Mechanisms of TGF-beta signaling from
cell membrane to nucleus. Cell 2003; 113: 685–700.
Article  CAS  Google Scholar 
10. Attisano L, Wrana JL . Signal transduction by the TGF-beta
superfamily. Science 2002; 296: 1646.
Article  CAS  Google Scholar 
11. Massague J . TGF-beta signal transduction. Annu Rev Biochem
1998; 67: 753–91.
Article  CAS  Google Scholar 
12. Dennler S, Huet S, Gauthier JM . A short amino-acid sequence
in MH1 domain is responsible for functional differences
between Smad2 and Smad3. Oncogene 1999; 18: 1643–8.
Article  CAS  Google Scholar 
13. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H,
et al. Targeted disruption of SMAD3 results in impaired
mucosol immunity and diminished T cell responsiveness to
TGF-beta. EMBO J 1999; 18: 1280–91.
Article  CAS  Google Scholar 
14. Weinstein M, Yang X, Li C, Xu X, Gotay J, Deng CX . Failure
of egg cylinder elongation and mesoderm induction in mouse
embryos lacking the tumor suppressor smad2. Proc Natl Acad
Sci USA 1998; 95: 9378–83.
Article  CAS  Google Scholar 
15. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL,
Weinstein M, et al. Functional chrarcterization of
transforming growth factor? signaling in Smad2 and Smad3–


deficient fibroblasts. J Biol Chem 2001; 276: 19 945–53.
Article  Google Scholar 
16. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA,
Lodish HF . Transforming growth factor beta-induced
phosphorylation of Smad3 is required for growth inhibition
and transcriptional induction in epithelial cells. Proc Natl
Acad Sci USA 1997; 94: 10669–74.
Article  CAS  Google Scholar 
17. Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, et
al. Smad3 deficiency attenuates bleomycin-induced
pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol
2002; 282: L585–93.
Article  CAS  Google Scholar 
18. Stegemann H, Stalder K . Determination of hydroxyproline.
Clin Chim Acta 1967; 18: 267–73.
Article  CAS  Google Scholar 
19. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita
A, et al. A soluble transforming growth factor beta receptor
expressed in muscle prevents liver fibrogenesis in rats. Hum
Gene Ther 2000; 11: 33–42.
Article  CAS  Google Scholar 
20. Giri SN, Hyde DM, Hollinger MA . Effect of transforming
growth factor-β on a bleomycin induced accumulation of lung
collagen in mice. Thorax 1993; 48: 959–66.
Article  CAS  Google Scholar 
21. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE,
Ryan ST, et al. Reduction of bleomycin induced lung fibrosis
by transforming growth factor-β soluble receptor in hamsters.
Thorax 1999; 54: 805–12.


Article  CAS  Google Scholar 
22. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto
J, Roberts AB, et al. SMAD3/4–dependent transcriptional
activation of the human type VII collagen gene (COL7A1)
promoter by transforming growth factor-β. Proc Natl Acad Sci
USA 1998; 95: 14769–74.
Article  CAS  Google Scholar 
23. Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J . Interaction
of Smad3 with a proximal smad-binding element of the
human alpha2 (I) procollagen gene promoter required for
transcriptional activation by TGF-beta. J Cell Physiol 2001;
183: 381 92.
Article  Google Scholar 
24. Verrecchia F, Chu ML, Mauviel A . Identification of novel
TGF-beta/Smad gene targets in dermal fibroblasts using a
combined cDNA microarray/promoter transactivation
approach. J Biol Chem 2001; 276: 17058–62.
Article  CAS  Google Scholar 
25. Dennler S, Itoh S, Vivien D, Ten Dijke, P, Huet S, Gauthier JM
. Direct binding of Smad3 and Smad4 to critical TGF beta-
inducible elements in the promoter of human plasminogen
activator inhibitor-type 1 gene. EMBO 1998; 17: 3091–100.
Article  CAS  Google Scholar 
26. Datta PK, Blake MC, Moses HL . Regulation of plasminogen
activator inhibitor-1 expression by transforming growth
factor-beta-induced physical and functional interactions
between smads and Sp1. J Biol Chem 2000; 275: 40014–9.
Article  CAS  Google Scholar 
27. Hu B, Wu Z, Phan SH . Smad3 mediates transforming growth
factor-beta-induced alpha-smooth muscle actin expression.
Am J Respir Cell Mol Biol 2003; 29: 397–404.


Article  CAS  Google Scholar 
28. Corjay MH, Thompson MM, Lynch KR, Owens GK .
Differential effect of platelet-derived growth factor-versus
serum-induced growth on smooth muscle alpha-actin and
nonmuscle beta-actin mRNA expression in cultured rat aortic
smooth muscle cell. J Biol Chem 1998; 264: 10501–6.
Google Scholar 
29. Mack CP, Owens GK . Regulation of smooth muscle alpha-
actin expression in vivo is dependent on CArG elements
within the 5′ and first intron promoter regions. Circ Res 1999;
84: 852–61.
Article  CAS  Google Scholar 
30. Cogan JG, Subramanian SV, Polikandriotis JA, Kelm RJ,
Strauch AR . Vascular smooth muscle α-actin gene
transcription during myofibroblast differentiation requires
sp1/3 protein binding proximal to the MCAT enhancer. J Biol
Chem 2002; 277: 36 433–42.
Article  Google Scholar 
31. Yuan W, Varga J . Transforming growth factor-beta
repression of matrix metal proteinase-1 transcription in
dermal fibroblasts involves Smad3. J Biol Chem 2001; 276:
38502–10.
Article  CAS  Google Scholar 
32. Derynck R, Zhang YE . Smad-dependent and Smad-
independent pathways in TGF-beta family signaling. Nature
2003; 425: 577–84.
Article  CAS  Google Scholar 
33. Sime PJ, O'Reilly KMA . Fibrosis of the lung and other tissues:
new concepts in pathogenesis and treatment. Clin immunol
2001; 99: 308–19.


Article  CAS  Google Scholar 
34. Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA,
Chinnaiyan AM, et al. FIZZ1 stimulation of myofibroblast
differentiation. Am J Path 2004; 164: 1315–26.
Article  CAS  Google Scholar 
35. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R .
Circulating fibrocytes: collagen-secreting cells of the
peripheral blood. Int J Biochem Cell Biol 2004; 36: 598–606.
Article  CAS  Google Scholar 
36. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH . Bone
marrow- derived progenitor cells in pulmonary fibrosis. J Clin
Invest 2004; 113: 243–52.
Article  CAS  Google Scholar 
Download references
Author information
Authors and Affiliations
1. Department of Pulmonary Medicine, Peking Union Medical
College Hospital, Chinese Academy of Medical Sciences,
Beijing, 100071, China
Li Gu, Yuan-jue Zhu, Zi-jian Guo, Wen-bing Xu & Xin-lun Tian
2. Department of Genetic Laboratory of Development and
Diseases, Institute of Biotechnology, Beijing, 100070, China
Xiao Yang
Authors
1. Li Gu


View author publications
Search author on:PubMed Google Scholar
2. Yuan-jue Zhu
View author publications
Search author on:PubMed Google Scholar
3. Xiao Yang
View author publications
Search author on:PubMed Google Scholar
4. Zi-jian Guo
View author publications
Search author on:PubMed Google Scholar
5. Wen-bing Xu
View author publications
Search author on:PubMed Google Scholar
6. Xin-lun Tian
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Yuan-jue Zhu.
Additional information
Project supported by the National Ministry of Education Doctor
Foundation of China (No 20020023045).
Rights and permissions


Reprints and permissions
About this article
Cite this article
Gu, L., Zhu, Yj., Yang, X. et al. Effect of TGF-β/Smad signaling
pathway on lung myofibroblast differentiation. Acta Pharmacol Sin
28, 382–391 (2007). https://doi.org/10.1111/
j.1745-7254.2007.00468.x
Download citation
•  Received: 15 July 2006
•  Accepted: 08 August 2006
•  Issue date: 01 March 2007
•  DOI: https://doi.org/10.1111/j.1745-7254.2007.00468.x
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
•  myofibroblasts
•  transforming growth factor β1
•  Smad


This article is cited by
•  The multifunctional adaptor protein HIP-55
couples Smad7 to accelerate TGF-β type I
receptor degradation
○  Yang Sun
○  Zi-jian Li
Acta Pharmacologica Sinica (2022)
•  PD-L1 mediates lung fibroblast to myofibroblast
transition through Smad3 and β-catenin
signaling pathways
○  Xia Guo
○  Christudas Sunil
○  Guoqing Qian
Scientific Reports (2022)
•  TRPM7 restrains plasmin activity and promotes
transforming growth factor-β1 signaling in
primary human lung fibroblasts
○  Sarah Zeitlmayr
○  Susanna Zierler
○  Andreas Breit
Archives of Toxicology (2022)
•  Hypoxic hUCMSC-derived extracellular vesicles
attenuate allergic airway inflammation and
airway remodeling in chronic asthma mice
○  Liyang Dong
○  Ying Wang


○  Chaoming Mao
Stem Cell Research & Therapy (2021)
•  Tenascin-C inactivation impacts lung structure
and function beyond lung development
○  Sandrine Gremlich
○  Matthias Roth-Kleiner
○  Tiziana P. Cremona
Scientific Reports (2020)
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Current issue
•  Collections
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  About the Editors
•  Editorial Board


•  About the Partner
•  Contact
•  For Advertisers
•  Subscribe
•  Open Access Fees and Funding
Publish with us
•  For Authors & Referees
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Acta Pharmacologica Sinica (Acta Pharmacol Sin)
ISSN 1745-7254 (online)
ISSN 1671-4083 (print)
nature.com sitemap


About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services


•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


